Pancreatic Neoplasms: all 3,311 studies

Page 19 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell SurfaceCompletedNCT04752215Phase 1
• Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.CompletedNCT04747600
• An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene TherapyStatus unknownNCT04739046Phase 2
• Laparoscopic Enucleation of Frantz's Tumor of the PancreasCompletedNCT04728750
• The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic FistulaCompletedNCT04724551
• The Transformation of Locally Advanced Pancreatic Cancer.Status unknownNCT04723030Phase 2
• Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE TrialCompletedNCT04721301Phase 1
• Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic CancerStatus unknownNCT04718701Phase 2
• Incentive Spirometry and Upper Abdominal Laparoscopic SurgeryCompletedNCT04716166Not applicable
• Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal AnastomosesStatus unknownNCT04709445Not applicable
• Heparin-based Wet Suction Method in EUS Fine Needle Biopsy of Solid Pancreatic MassStatus unknownNCT04707560Not applicable
• Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus ChemotherapyStatus unknownNCT04707118Phase 1
• Combining Epigenetic And Immune Therapy to Beat Cancer.CompletedNCT04705818Phase 2
• Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLsStatus unknownNCT04687410Not applicable
• CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept TrialStatus unknownNCT04683497Not applicable
• Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic MetastasisStatus unknownNCT04677192Phase 2
• A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerStatus unknownNCT04674956Phase 3
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04673448Phase 1
• Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic CancerActive, not recruitingNCT04672005Phase 2
• Improvement of Care of Patients Undergoing PancreaticoduodenectomyCompletedNCT04668781Not applicable
• Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic CancerStatus unknownNCT04667403Not applicable
• LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT04666688Phase 1/2
• First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic CancerActive, not recruitingNCT04665947Early Phase 1
• Routine Staple Line Reinforcement for Minimally Invasive Distal PancreatectomyStatus unknownNCT04663789Not applicable
• Evaluation of Difficulty Score for Robotic PancreatoduodenectomyStatus unknownNCT04662346Not applicable
• International Pancreatic Surgery Outcomes Study - PancreasGroup.OrgStatus unknownNCT04652271
• Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive, not recruitingNCT04644068Phase 1/2
• APG-1387 Plus Chemotherapy in Advanced Pancreatic AdenocarcinomaTerminatedNCT04643405Phase 1/2
• Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With TumorsCompletedNCT04640480Phase 1
• Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCsStatus unknownNCT04638868Not applicable
• ARGONAUT: Stool and Blood Sample Bank for Cancer PatientsSuspendedNCT04638751
• OH2 Oncolytic Viral Therapy in Pancreatic CancerTerminatedNCT04637698Phase 1/2
• Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic CancerCompletedNCT04634539Phase 1
• Early Palliative Care for Patients With Advanced Pancreatic Cancer.Active, not recruitingNCT04632303Not applicable
• Study Evaluating the Ketogenic Diet in Patients with Metastatic Pancreatic CancerCompletedNCT04631445Not applicable
• A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic CancerCompletedNCT04624217Phase 1/2
• Percutaneous Versus EUS FNAC in Pancreatic MassesStatus unknownNCT04623749Not applicable
• AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerStatus unknownNCT04617821Phase 3
• Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic CancerCompletedNCT04617067Phase 2
• PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic CancerStatus unknownNCT04612530Phase 1
• Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PACActive, not recruitingNCT04605913Phase 1/2
• Pancreatic Cancer Recurrence in the NetherlandsStatus unknownNCT04605237
• Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM)Status unknownNCT04605042Not applicable
• Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsCompletedNCT04604158Not applicable
• The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric CancerCompletedNCT04602026Not applicable
• MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer PatientsStatus unknownNCT04600154Not applicable
• Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
• Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic AdenocarcinomaActive, not recruitingNCT04594772Phase 2
• Carbon Ion RT for Locally Advanced Pancreatic CancerTerminatedNCT04592861Phase 3
• Pancreas Cancer Surveillance Using an Abbreviated MRIActive, not recruitingNCT04592393Not applicable
• Saltikva for Metastatic Pancreatic CancerActive, not recruitingNCT04589234Phase 2
• Implementing Acupuncture and Chinese Herbal Medicine Into Palliative CareWithdrawnNCT04584775Not applicable
• The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic CancerStatus unknownNCT04581876Phase 2
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionActive, not recruitingNCT04581473Phase 1/2
• A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT04571489Phase 2
• CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic CancerCompletedNCT04560270Not applicable
• 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)CompletedNCT04553926
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsActive, not recruitingNCT04550494Phase 2
• Biomarkers of Pancreatic Cancer and New Way to DetectionStatus unknownNCT04549064
• Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsActive, not recruitingNCT04548752Phase 2
• Supportive Oncology Care At Home RCTActive, not recruitingNCT04544046Not applicable
• Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaActive, not recruitingNCT04543071Phase 2
• The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer PatientsCompletedNCT04528745
• The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical PatientsStatus unknownNCT04524260Not applicable
• PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic CancerStatus unknownNCT04518800Not applicable
• Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational OncologyCompletedNCT04512209Not applicable
• Role of EUS in Detection of Liver MetastasisCompletedNCT04509492
• Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic CancerStatus unknownNCT04498689Phase 2
• NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic CancerActive, not recruitingNCT04484909Phase 1
• PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)CompletedNCT04484636Not applicable
• A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsActive, not recruitingNCT04482309Phase 2
• Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.Status unknownNCT04482257Phase 1
• A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT04477343Phase 1
• Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for CancerTerminatedNCT04469504Not applicable
• Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
• Pancreatic Anastomosis After DuodenopancreatectomyCompletedNCT04462354Not applicable
• Pulse-low-dose Rate (PLDR) Radiation in Pancreatic CancerActive, not recruitingNCT04452357Not applicable
• Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyCompletedNCT04449679Not applicable
• Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of BiomarkersActive, not recruitingNCT04449406
• Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic CancerActive, not recruitingNCT04447092Phase 2
• INTER-Regional COHORTE of Long Term Pancreatic Cancer SurvivorsCompletedNCT04436679
• Patient Reported Outcomes Measures to Predict Pancreatic Surgery OutcomesActive, not recruitingNCT04431076
• A Study of the Life Changes Experienced by Patients With Pancreatic CancerActive, not recruitingNCT04427761
• A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringCompletedNCT04426669Phase 1/2
• A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic CancerStatus unknownNCT04425876Phase 1
• Evolution of Body Connection After SurgeryCompletedNCT04422730
• A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）WithdrawnNCT04420130Not applicable
• Intravenous Human Albumin In Improving Pancreaticoduodenectomy OutcomesStatus unknownNCT04418739Phase 2
• A New Anatomical Classification of Portal Vein Location of Pancreas TumorsCompletedNCT04416685Not applicable
• The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic CarcinomaStatus unknownNCT04415385Phase 2
• Claudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive CancersActive, not recruitingNCT04404595Phase 1/2
• Monitoring Heart Rate Variability for the Early Detection of Pancreatic CancerTerminatedNCT04400903
• Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary TumorsCompletedNCT04400357Not applicable
• A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsActive, not recruitingNCT04396821Phase 1/2
• Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT04390399Phase 2
• Reoperation After PancreaticoduodenectomyStatus unknownNCT04387903
• Advanced Endoscopy During COVID-19CompletedNCT04385147
• Covid-19 Pandemic and Pancreatic Surgery in ItalyCompletedNCT04380766
• Validations of New cut-of for the Stratification of Postoperative Complications,Drains ManagementStatus unknownNCT04380506Not applicable
• Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic CancerStatus unknownNCT04377048Phase 2

← Pancreatic Neoplasms overview